ArticleAvicenna journal of phytomedicine
Urolithin A safeguards against diabetes-induced pathospermia and embryotoxicity in rats.
Article in Avicenna journal of phytomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Diabetes mellitus (DM) as a chronic disease can negatively affect male fertility due to endocrine and metabolic pathways disruption. This study was implemented to appraise the possible beneficial effects of urolithin A (UA), a natural polyphenol produced by the gut microbiota, against DM adverse effects on epididymal sperms and pre-implantation embryo development in mature rats. Materials and Methods: Forty mature male Wistar rats were randomly allocated to five equal groups including non-treated control group, DM group administered with intra-peritoneal streptozotocin (50 mg/kg), and three treated diabetic groups which received 25, 100, and 400 mg/kg of UA for 60 days orally. Thereafter, serum levels of testosterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH), and testicular total anti-oxidant capacity (TTAC) and malondialdehyde (TMDA), as well as sperm quantity and quality, Results: The UA exerted dose-dependent protective effects against DM-related negative impacts on biochemical (testosterone, FSH, LH, TTAC, and TMDA), spermatological (sperm count, motility, viability, and chromatin and DNA qualities), Conclusion: This study's outcomes spotlighted the promising protective functions of UA in DM-associated male reproductive disorders in rats, owing its weighty anti-oxidative properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.